BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Providence Medical Technology Receives 510(k) Clearance for PMT Bone Screws


10/25/2012 6:52:07 AM

SAN FRANCISCO--(BUSINESS WIRE)-- Providence Medical Technology today announced that the company has received 510(k) clearance from the FDA to market PMT Bone Screws in the U.S.

“This clearance represents an important step in broadening our posterior cervical platform of single use disposable instruments and implants,” commented Jeff Smith, Chief Executive Officer of Providence Medical Technology. “Posterior indirect decompression and fusion provides a compelling minimally-invasive alternative for patients suffering from cervical radiculopathy.”

The PMT Bone Screws are indicated for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation appropriate for the size of the device. Screws are intended for single use only.

Providence’s posterior cervical platform now consists of DTRAX® Graft, DTRAX Cervical System, and PMT Bone Screws in the U.S., and the DTRAX Facet System outside of the U.S. Providence is finalizing manufacturing plans for the PMT Bone Screws and related delivery systems, and anticipates full market release during the first half of 2013.

“I am encouraged by our team’s ability to develop new products and gain necessary regulatory clearances to support our growing DTRAX platform,” continued Smith. “We have launched two new products in the U.S. in 2012, and anticipate two additional products in 2013.”

Providence’s product portfolio and pipeline will be on display at the North American Spine Society (NASS) Annual Meeting, October 24-27, at the Dallas Convention Center, at Booth #2915.

About Providence

Providence Medical Technology is a private corporation focused on developing novel minimally invasive technologies. We are commercializing the DTRAX platform of posterior cervical devices, which are used to provide indirect decompression and fusion in patients suffering from cervical degenerative disease.

Contact:

Providence Medical Technology

David Schummers, 415-923-9376

info@providencemt.com



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES